Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Mylan Pharmaceuticals has obtained FDA approval for the abbreviated new drug application of generic Detrol tablets indicated for overactive bladder causing urge urinary incontinence, urgency and frequency.
Subscribe to our email newsletter
Tolterodine tartrate tablet of 1mg and 2mg dose strengths is generic equivalent to Pharmacia and Upjohn’s Detrol tablet containing a muscarinic receptor antagonist tolterodine.
Tolterodine has a pronounced effect on bladder function and shows significant therapeutic effect.
US sales of generic overactive bladder medication were $61.5m for 12 months ending 30 September 2012, according to IMS Health data.